We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Light Switch Added to Oligomers Improves Precision of Gene-Blocking Studies

By LabMedica International staff writers
Posted on 23 May 2012
Scientists collaborating with a company that synthesizes antisense oligomers have tested a new Ultraviolet (UV) light-activated on-off switch linked to these molecules. More...
Based on initial testing, the enhanced oligomers promise to deliver detailed insights from studies in fields such as developmental biology and neuroscience.

The team described the advancement in a paper published May 1, 2012, in the journal Development. Philip Washbourne, professor of biology at the Institute of Neuroscience of the University of Oregon (Eugene, USA), says the paper is a proof-of-concept on an idea he discussed with scientists at Gene Tools LLC (Philomath, OR, USA), which produces “Morpholino” oligonucleotides, a form of synthetic short-chain antisense (or sense) oligomers used to block gene function by RNA-binding.

Biologists have been using morpholinos in zebrafish and other model organisms to study development, but the molecules remained in the "on" (active) state. Gene Tools introduced a light-sensitive linker, allowing researchers to control the photo-morpholinos temporally and spatially — even leaving one "on" in one cell and "off" in an adjacent cell — with a pinpoint UV laser beam.

University of Oregon researchers in Westbourne’s lab, led by research associate Alexandra Tallafuss, were challenged to give the new molecules a test run in zebrafish. "Now we can turn them on and off," Prof. Washbourne said, "you can insert them and then manipulate them to learn just when a gene is important, and we learned two things right away." Researchers have known that if the "no tail" gene is blocked in development, zebrafish fail to grow tails. With the new photo-cleavable morpholinos, they discovered that the no-tail gene does not need to produce protein for tail formation until about 10 hours, or very late, into an embryo's development. Secondly, the researchers looked at the gene sox10 that is vital in the formation of neural crest cells. "Again, we found that sox10 is not needed as early in development as theorized," Prof. Washbourne said.

"These light-sensitive molecules significantly expand the power and precision of molecular genetic studies in zebra fish," said Robert Riddle, a program director at the National Institute of Neurological Disorders and Stroke (NINDS); "Researchers from many fields will be able to use these tools to explore the function of different genes in embryonic regions, specific cell types, and at precise times in an animal's lifespan."

Related Links:
Institute of Neuroscience, University of Oregon
Gene Tools LLC



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.